Related Experiment Video
Updated: May 18, 2026

Optimization of High Grade Glioma Cell Culture from Surgical Specimens for Use in Clinically Relevant Animal Models and 3D Immunochemistry
Published on: January 7, 2014
The future of glioma treatment: stem cells, nanotechnology and personalized medicine
Maryam Rahman1, Brian Hoh, Nathan Kohler
1Department of Neurosurgery, University of Florida, Box 100265, Gainesville, FL 32610, USA. maryam.rahman@neurosurgery.ufl.edu
Abstract:
The development of novel therapies, imaging techniques and insights into the processes that drive growth of CNS tumors have allowed growing enthusiasm for the treatment of CNS malignancies. Despite this energized effort to investigate and treat brain cancer, clinical outcomes for most patients continue to be dismal. Recognition of diverse tumor subtypes, behaviors and outcomes has led to an interest in personalized medicine for the treatment of brain tumors. This new paradigm requires evaluation of the tumor phenotype at the time of diagnosis so that therapy can be specifically tailored to each individual patient. Investigating novel therapies involving stem cells, nanotechnology and molecular medicine will allow diversity of therapeutic options for patients with brain cancer. These exciting new therapeutic strategies for brain tumors are reviewed in this article.
Insights
Despite advances in treating central nervous system (CNS) tumors, outcomes remain poor. Personalized medicine, focusing on tumor phenotype and novel therapies like stem cells, offers new hope for brain cancer patients.
Area of Science:
- Neuro-oncology
- Cancer therapy
- Molecular medicine
Background:
- Central nervous system (CNS) tumors present a significant challenge in oncology.
- Despite advancements in therapies and imaging, clinical outcomes for CNS malignancies remain dismal.
- Diverse tumor subtypes necessitate individualized treatment approaches.
Purpose of the Study:
- To review novel therapeutic strategies for brain tumors.
- To highlight the importance of personalized medicine in CNS oncology.
- To discuss emerging treatment options including stem cells, nanotechnology, and molecular medicine.
Main Methods:
- Literature review of recent advancements in CNS tumor research.
- Analysis of emerging therapeutic modalities.
- Discussion of personalized medicine paradigms in neuro-oncology.
Main Results:
- Novel therapies including stem cells, nanotechnology, and molecular medicine show promise.
- Personalized medicine, based on tumor phenotype, is crucial for tailoring treatment.
- Despite progress, significant challenges in improving patient outcomes persist.
Conclusions:
- Personalized medicine and novel therapeutic strategies are essential for advancing brain tumor treatment.
- Further research into stem cells, nanotechnology, and molecular medicine is warranted.
- Tailoring therapy to individual tumor characteristics offers the best hope for improving patient outcomes in CNS malignancies.
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...

